Cutler Group’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q1 | – | Sell |
-1,900
| Closed | -$19K | – | 1759 |
|
2023
Q4 | $19K | Hold |
1,900
| – | – | ﹤0.01% | 863 |
|
2023
Q3 | $19K | Buy |
+1,900
| New | +$19K | ﹤0.01% | 893 |
|
2023
Q1 | – | Sell |
-16,395
| Closed | -$149K | – | 2172 |
|
2022
Q4 | $149K | Sell |
16,395
-14,472
| -47% | -$132K | 0.01% | 519 |
|
2022
Q3 | $249K | Sell |
30,867
-6,806
| -18% | -$54.9K | 0.02% | 430 |
|
2022
Q2 | $283K | Buy |
37,673
+5,016
| +15% | +$37.7K | 0.02% | 370 |
|
2022
Q1 | $306K | Buy |
32,657
+27,957
| +595% | +$262K | 0.02% | 470 |
|
2021
Q4 | $37K | Buy |
+4,700
| New | +$37K | ﹤0.01% | 1286 |
|
2021
Q3 | – | Hold |
0
| – | – | – | 2701 |
|
2021
Q2 | – | Hold |
0
| – | – | – | 2695 |
|
2021
Q1 | – | Sell |
-14,900
| Closed | -$143K | – | 2634 |
|
2020
Q4 | $143K | Sell |
14,900
-3,728
| -20% | -$35.8K | 0.01% | 668 |
|
2020
Q3 | $167K | Hold |
18,628
| – | – | 0.01% | 530 |
|
2020
Q2 | $229K | Sell |
18,628
-4,800
| -20% | -$59K | 0.02% | 414 |
|
2020
Q1 | $210K | Buy |
23,428
+7,712
| +49% | +$69.1K | 0.01% | 410 |
|
2019
Q4 | $154K | Buy |
15,716
+5,900
| +60% | +$57.8K | 0.01% | 578 |
|
2019
Q3 | $67K | Sell |
9,816
-4,434
| -31% | -$30.3K | 0.01% | 719 |
|
2019
Q2 | $131K | Buy |
14,250
+14,116
| +10,534% | +$130K | 0.01% | 610 |
|
2019
Q1 | $2K | Sell |
134
-3,100
| -96% | -$46.3K | ﹤0.01% | 1382 |
|
2018
Q4 | $49K | Hold |
3,234
| – | – | ﹤0.01% | 838 |
|
2018
Q3 | $69K | Buy |
3,234
+600
| +23% | +$12.8K | ﹤0.01% | 848 |
|
2018
Q2 | $64K | Sell |
2,634
-3,366
| -56% | -$81.8K | 0.01% | 835 |
|
2018
Q1 | $102K | Buy |
6,000
+4,566
| +318% | +$77.6K | 0.01% | 725 |
|
2017
Q4 | $27K | Sell |
1,434
-37,474
| -96% | -$706K | ﹤0.01% | 1302 |
|
2017
Q3 | $684K | Sell |
38,908
-56,989
| -59% | -$1M | 0.03% | 349 |
|
2017
Q2 | $3.19M | Sell |
95,897
-48,986
| -34% | -$1.63M | 0.12% | 112 |
|
2017
Q1 | $4.65M | Buy |
144,883
+107,779
| +290% | +$3.46M | 0.19% | 85 |
|
2016
Q4 | $1.35M | Buy |
37,104
+21,518
| +138% | +$780K | 0.05% | 228 |
|
2016
Q3 | $717K | Buy |
15,586
+13,574
| +675% | +$624K | 0.03% | 303 |
|
2016
Q2 | $101K | Buy |
2,012
+1,551
| +336% | +$77.9K | 0.01% | 1015 |
|
2016
Q1 | $24K | Buy |
461
+161
| +54% | +$8.38K | ﹤0.01% | 1649 |
|
2015
Q4 | $19K | Buy |
+300
| New | +$19K | ﹤0.01% | 1892 |
|